fda glp-1 warning letters october 2025 news The has announced that it has given us an expedited review of the once-a-day weight loss pill we're investigating, potentially giving people living with obesity a new treatment option early next FDA warnings against compounded GLP-1s

Jean-Gilles, DO, FACOG , and his team of leading healthcare professionals today

The weight loss medications that we prescribe as a part of our weight loss program in Stockton, California, whether they are GLP-1 medications or non- GLP-1 medications, help people lose weight through different mechanisms, making them suitable for various needs and health profiles

Grover M, Bernard CE, Pasricha PJ, et al

For many adults, a more structured Medical Weight Loss Program can help connect medication use with practical nutrition habits, follow-up, and activity planning

In one of the most consequential healthcare deals of the year, President Trumps new drug-pricing pact with Eli Lilly and Novo Nordisk slashes the cost of blockbuster GLP-1 drugs like Wegovy and Zepbound, turning a luxury medicine into a mainstream benefitand forcing Ro, Hims, Mochi Health, and other telehealth players to rethink their most lucrative business model

Break the cycle of emotional eating Rebuild your relationship with food Create healthy routines Stay accountable and supported Focus on long-term success GLP-1 medications We offer a variety of GLP-1 medications for eligible patients, with Semaglutide and Tirzepatide as our most commonly prescribed options